Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Ciscom Corp. Strengthens Its Board of Directors with Addition of Two Experienced Industry Leaders (click to learn more) Silver North Options GDR Silver Project, Silvertip-Midway District, Yukon (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Avivagen Inc V.VIV

Alternate Symbol(s):  VIVXF

Healthcare
Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is... see more

Recent & Breaking News (TSXV:VIV)

Avivagen Announces Chief Executive Officer and Issuance of Third Quarter Results

TheNewsWire September 7, 2017

Avivagen Announces Scale Up of Commercial Roll Out for OxC-beta™ Livestock in the Philippines

GlobeNewswire August 16, 2017

Avivagen Announces Scale Up of Commercial Roll Out for OxC-bet(TM) Livestock in the Philippines

TheNewsWire August 16, 2017

Cesar Millan to Endorse Avivagen’s Companion Animal Health Product Vivimune Health Chews

GlobeNewswire July 10, 2017

Cesar Millan to Endorse Avivagen's Companion Animal Health Product Vivimune Health Chews

TheNewsWire July 10, 2017

Avivagen Retains Hybrid Financial Inc. for Investor Relations Activities

GlobeNewswire July 4, 2017

Avivagen, Inc. to Present at The MicroCap Conference on June 27th in Toronto at the Sheraton Centre Hotel

Accesswire June 8, 2017

Avivagen Provides Business Updates

GlobeNewswire June 5, 2017

Avivagen Announces Grant of Stock Options

TheNewsWire May 30, 2017

Avivagen Announces Third Purchase Order of OxC-Beta™ Livestock from UNAHCO Inc.

GlobeNewswire May 26, 2017

Avivagen Announces Third Purchase Order of OxC-Beta (tm) Livestock from UNAHCO Inc.

TheNewsWire May 26, 2017

Avivagen Announces Completion of Share Consolidation

GlobeNewswire May 24, 2017

Avivagen Announces Completion of Share Consolidation and Issuance of 2nd Quarter Results

TheNewsWire May 24, 2017

Avivagen Announces Engagement of Regulatory Consulting Firm

GlobeNewswire May 12, 2017

Avivagen Inc. Announces Consolidation of Common Shares

GlobeNewswire May 8, 2017

Avivagen Announces Presentation at the Bloom Burton & Co. Healthcare Investor Conference on May 2, 2017

GlobeNewswire April 26, 2017

Avivagen Announces Results From its Annual and Special Meeting of Shareholders

TheNewsWire April 12, 2017

Avivagen Reports Positive Proof of Concept in Preventing C. Difficile Infection

GlobeNewswire April 10, 2017

Avivagen Announces a Follow-On Purchase Order of OxC-Beta(TM) Livestock From UNAHCO, Inc.

TheNewsWire April 6, 2017

Avivagen Announces a Follow-On Purchase Order of OxC-Beta™ Livestock From UNAHCO, Inc.

GlobeNewswire April 6, 2017